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A B S T R A C T
The current global propagation of COVID-19 is heterogeneous, with slow transmission continuing in
many countries and exponential propagation in others, where the time that it took for the explosive
spread to begin varied greatly. It is proposed that this could be explained by cascading superspreading
events, in which new infections caused by a superspreader are more likely to be highly infectious. The
mechanism suggested for this is related to viral loads. Exposure to high viral loads may result in high-
intensity infection, which exposes new cases to high viral loads. This notion is supported by experimental
veterinary research.
© 2020 The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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journal home page: www.elsevier .com/ locat e/ i j idThe patterns of propagation of the severe acute respiratory
syndrome (SARS) outbreak of 2003 were not explained by
conventional epidemic models that assumed homogeneity of
infectiousness. Instead, the existing datasets were best matched by
models that used negative binomial distributions, in which a small
proportion of cases were highly infectious (Lloyd-Smith et al.,
2005; McDonald et al., 2004; Shen et al., 2004). Data and modelling
supported the existence of superspreaders, which played a crucial
role in propagating the disease by being very efficient at
transmitting SARS-CoV-1, such that in the absence of super-
spreading events most cases infected few, if any, secondary
contacts (Stein, 2011). Almost a decade later the Middle East
respiratory syndrome coronavirus (MERS-CoV) emerged, with
analogous infection dynamics involving superspreading events
(Hui, 2016).
Similarly, early modelling and data suggest that a small
proportion of cases of COVID-19 were responsible for most
transmissions, which is evidence that superspreaders also play
an important role in SARS-CoV-2 (MacKenzie, 2020; Frieden and
Lee, 2020). Explanations for this superspreader status include high
viral shedding due to poor immunocompetence, underlying
diseases or co-infection, or elevated contact rate due to active* Corresponding author at: RP Kreder 2805, 3080 Esperanza, Santa Fe, Argentina.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).social behaviour (Bassetti et al., 2005; Lloyd-Smith et al., 2005;
McDonald et al., 2004; Shen et al., 2004; Wong et al. 2015).
The propagation of SARS-CoV-2 has shown it to be heteroge-
neous at a global scale (data publicly shared by the World Health
Organization and Johns Hopkins University). After the virus started
to be reported outside of China, cases were infecting fewer people
than expected compared with the rate of spread in China.
Nonetheless, by the end of February, when over 50 countries
outside China had confirmed the infection, South Korea, Italy and
Iran presented notable spread. During the first month of viral
propagation in south Korea there were two to three reports of new
infections per day. However, the rapid spread began after one case
was linked to 3,900 secondary cases in Daegu (Shim et al., 2020).
In Italy, the rapid surge of cases began in a cluster in Lombardy
after an infected man was hospitalised without precautionary
measures and infected other patients (mostly elderly people) and
health workers. Apparently, there was no calm period in Iran,
where the first two reported cases were fatal. Two weeks later
there were 1,500 cases, and after 1 month there were >17,000
reported infections. A few weeks later, several other countries
underwent a similar exponential growth in the number of cases,
despite many of them taking drastic measures to control the
pandemic. A notable case was the USA, where the infection
propagated slowly from 20 January to early March, when the daily
growth in the number of cases suddenly went from being of one
digit to surpassing 30%, remaining above that geometrical growth
rate for almost 20 days. This explosive spread began in New York for Infectious Diseases. This is an open access article under the CC BY-NC-ND license
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weeks. In contrast, the infection propagated at a slow to moderate
pace in most countries such as Thailand, Singapore, Egypt, Finland,
Japan, Australia, and many others. In general, there have also been
contrasts in the apparent case-fatality rate (deaths/reported)
depending on the speed of propagation, being much lower in
countries with slow spread (e.g. 0.1% in Singapore, 1.4% in Australia
and 1.8% in Thailand) compared with those where the transmission
was notably high (e.g. 14% in Italy, 12% in Spain, 7% in USA). This
difference might be too large to be solely explained by detection
bias.
It appears that SARS-CoV-2 spreads gradually within a region
unless a chain reaction of transmission is triggered. Independent
superspreading events due to individual variation cannot explain
this large-scale heterogeneous pattern of transmission. The
occurrence of superspreaders may not be at random and may
depend on other superspreaders. It is proposed that infections
caused by contact with superspreaders are more likely to result in
new superspreaders than those caused by transmission from a less
infectious individual. The mechanism by which this would be
possible is by exposure to differential viral load. The primary mode
of transmission of SARS-CoV-2 appears to be through exposure to
respiratory droplets and direct contact with infected individuals
and their contaminated environment (Xiao et al., 2017; van
Doremalen et al., 2020). Droplets may contain a few or a million
viral particles, and this differential load determines how much the
environment is contaminated and the infective dose a susceptible
person is exposed to. A case with a high intensity of infection has
the potential of being a superspreader due to high viral shedding.
Susceptible people exposed to this hypothetical superspreader
would be exposed to a high viral dose. Infections resulting from
exposure to high loads of virus are expected to be of high intensity,
as a large quantity of viral particles initiating replication in
synchrony might overwhelm the mechanisms of resistance, and
the poor control of viral replication may therefore result in a new
potential superspreader.
This hypothesis has support from veterinary research. For
example, in a recent study, calves were experimentally infected by
bovine viral diarrhoea virus (an RNA Pestivirus that is transmitted
via droplets) at three different viral doses (Strong et al., 2015). The
outcome of infection was dose dependent, with animals given a
higher dose developing severe disease and more pronounced viral
replication and shedding. Moreover, sentinel calves housed with
the low-dose-infected group did not become infected, despite viral
shedding being confirmed. Other experimental infections also
found that viral dose positively correlated with disease severity
and viral shedding in other virus-domestic animal systems such as
feline viral rhinotracheitis in cats (Gaskell and Povey, 1979), low
pathogenic avian influenza virus in chickens (Zarkov and Bochev,
2008) and equine influenza in horses (Mumford et al., 1990).
Under the hypothesis posited here, cases with low-to-
moderate intensity of infection would mainly yield new
infections of low-to-moderate severity and viral shedding in
people who are not in risk groups. Occurrence of cases of high-
intensity infection could result in new cases that are of high viral
replication, generating a ‘domino effect’. The severity of disease
caused by high viral loads is expected to be high. This would be
due to extensive cell damage caused by large amounts of virus
and also due to the resulting immune response. The virulence
arising from an infection by SARS-CoV-2 is related to inflamma-
tory self-damage (Qin et al., 2020), and it is expected that an
infection initiated by a large number of viral particles would
generate a stronger immune response compared with infections
caused by a low viral dose. Therefore, a case resulting from
exposure to high viral loads has the potential to develop severe
disease and also of being highly infectious. It was found that theseverity of disease in MERS patients was positively correlated
with viral load (Min et al., 2016), and the same was recently
reported for COVID-19 (Liu et al., 2020; Zou et al., 2020).
It could be argued that individuals with higher viral loads are
more likely to be hospitalised or die, and therefore less likely to
contribute to community transmission as superspreaders. How-
ever, it should be considered that the outcome of an exposure to a
high viral dose largely depends on the tolerance (ability to reduce
the damage of an infection) of an individual (Råberg et al., 2009).
Given equal resistance (ability to limit the infection), exposure to
high viral loads will result in severe disease in the less tolerant and
high infection intensity with few manifestations in the more
tolerant. The latter case is of special concern because in these
individuals the clinical signs would be mild or absent, and
therefore likely to be undetected, exposing many people to high
viral loads. On the other hand, severe cases may be important
sources of disease in hospitals (Wang et al., 2020). For example, in
Argentina, 17% of the cases reported to date are healthcare workers
(Infobae, 2020). Therefore, the presence of superspreaders in
hospitals could make them nodes, where cascades of super-
spreading events emerge, which is consistent with what was
observed in Lombardy.
Disease is traditionally studied as a binary outcome: infected or
non-infected. The concepts presented here alert us to the value of
studying disease as a continuous variable (i.e. infection intensity)
(Beldomenico and Begon, 2010). Measuring the intensity of an
infection is crucial because it may be related to the virulence as
well as infectiousness. There are many studies of different viral
diseases in which the length of viral shedding is recorded, yet very
few produced data on the viral shedding load. The hypothesis
posited here needs to be tested by empirical and theoretical
studies, but this requires that data on viral load (viraemia and
shedding) are urgently collected. If superspreaders generate new
superspreaders by exposing susceptible people to large viral loads,
this mechanism should be immediately acknowledged and
considered in the responses being undertaken. In particular,
emphasis should be placed on the isolation or strict distancing of
people of risk groups, as they would not only have more chances of
developing a more severe disease (with the potential of
overwhelming the health system) but they could also be sources
of high viral loads. In addition, aggressive contact tracing and
testing would allow quick identification of tolerant super-
spreaders, who might be key elements of propagation.
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